Condition: Cardiac Arrythmias · Left Atrial Appendage Closure · Sponsor: Abbott Medical Devices
This study is a prospective, acute, first-in-human, early feasibility study intended to assess the initial safety and performance of the Agilis™ Radiofrequency (RF) Transseptal (TSP) System in crossing the atrial septum for left atrial and left ventricular access during cardiac electrophysiology (EP) and interventional cardiology (IC) procedures. This study will be conducted in an acute setting. Subjects will be followed through hospital discharge, and no follow-up visits will be required for this study.
This description comes directly from the study's public registry record.
Ben Gansemer, PhD · +1 952-715-2719 · benjamin.gansemer@abbott.com
Amber Miller, PhD · 612-413-7236 · amber.miller@abbott.com
Always discuss trial participation with your own doctor first.
| Arrhythmia Research Group (St. Bernards) | Jonesboro, Arkansas, United States | Recruiting |
| California Pacific Medical Center -Van Ness Campus | San Francisco, California, United States | Recruiting |
| Research Medical Center | Kansas City, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07361445